Trial Profile
Effect of ombitasvir/paritaprevir/ritonavir (ombitasvir/ABT-450/r) and dasabuvir with or without ribavirin (RBV) co-administered with HIV protease inhibitors (atazanavir, darunavir, lopinavir) in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2015
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Atazanavir; Darunavir; Lopinavir/ritonavir
- Indications Hepatitis C
- Focus Pharmacokinetics
- 17 Feb 2015 New trial record